These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10889187)

  • 1. Human plasmin enzymatic activity is inhibited by chemically modified dextrans.
    Ledoux D; Papy-Garcia D; Escartin Q; Sagot MA; Cao Y; Barritault D; Courtois J; Hornebeck W; Caruelle JP
    J Biol Chem; 2000 Sep; 275(38):29383-90. PubMed ID: 10889187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G.
    Ledoux D; Merciris D; Barritault D; Caruelle JP
    FEBS Lett; 2003 Feb; 537(1-3):23-9. PubMed ID: 12606025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by dextran derivatives of FGF-2 plasmin-mediated degradation.
    Meddahi A; Lemdjabar H; Caruelle JP; Barritault D; Hornebeck W
    Biochimie; 1995; 77(9):703-6. PubMed ID: 8789459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF protection and inhibition of human neutrophil elastase by carboxymethyl benzylamide sulfonate dextran derivatives.
    Meddahi A; Lemdjabar H; Caruelle JP; Barritault D; Hornebeck W
    Int J Biol Macromol; 1996 Feb; 18(1-2):141-5. PubMed ID: 8852763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycan mimetics (RGTA) modulate adult skeletal muscle satellite cell proliferation in vitro.
    Papy-Garcia D; Barbosa I; Duchesnay A; Saadi S; Caruelle JP; Barritault D; Martelly I
    J Biomed Mater Res; 2002 Oct; 62(1):46-55. PubMed ID: 12124786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of catalytic and lysine-binding sites in plasmin-induced neutrophil adherence to endothelium.
    Lo SK; Ryan TJ; Gilboa N; Lai L; Malik AB
    J Clin Invest; 1989 Sep; 84(3):793-801. PubMed ID: 2569479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of plasmin-mediated prostromelysin-1 activation by interaction of long chain unsaturated fatty acids with kringle 5.
    Huet E; Cauchard JH; Berton A; Robinet A; Decarme M; Hornebeck W; Bellon G
    Biochem Pharmacol; 2004 Feb; 67(4):643-54. PubMed ID: 14757164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding and activation of plasminogen at the surface of Staphylococcus aureus. Increase in affinity after conversion to the Lys form of the ligand.
    Kuusela P; Saksela O
    Eur J Biochem; 1990 Nov; 193(3):759-65. PubMed ID: 1701146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of plasmin activity by sulfated polyvinylalcohol-acrylate copolymers.
    Vörös G; Kolev K; Csomor K; Machovich R
    Thromb Res; 2000 Nov; 100(4):353-61. PubMed ID: 11113279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of RG1192, a substituted dextran, on inflammatory response.
    Li P; Cebrian J; Carpentier G; Barbosa I; Barritault D
    Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL409-13. PubMed ID: 14995069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM; Pizzo SV
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.
    Lin LF; Houng A; Reed GL
    Biochemistry; 2000 Apr; 39(16):4740-5. PubMed ID: 10769130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of staphylokinase with different molecular forms of plasminogen.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1993 Jan; 211(1-2):91-7. PubMed ID: 8425556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trinitrobenzoylated poly(D-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator.
    Petersen LC; Suenson E
    Biochim Biophys Acta; 1986 Sep; 883(2):313-25. PubMed ID: 2943320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
    Anonick PK; Vasudevan J; Gonias SL
    Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivative(s).
    Moroy G; Bourguet E; Decarme M; Sapi J; Alix AJ; Hornebeck W; Lorimier S
    Biochem Pharmacol; 2011 Mar; 81(5):626-35. PubMed ID: 21146503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of specifically chemically modified dextrans with transforming growth factor beta1: potentiation of its biological activity.
    Logeart-Avramoglou D; Huynh R; Chaubet F; Sedel L; Meunier A
    Biochem Pharmacol; 2002 Jan; 63(2):129-37. PubMed ID: 11841786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.